Riskpilot← Back to searchSign inGet full accessBiomet 3i Nordic AB
ABIn liquidationOrg 5566418934Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20030 employees
Revenue 2021
SEK 0
EBITDA margin
—
-91% vs 2020
Equity ratio
99.7%
Financial strength
Net profit 2021
SEK -214K
-88% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -214K | -91% |
| Net profit | SEK -214K | -88% |
| Total assets | SEK 16,3M | -1% |
| Equity | SEK 16,2M | -1% |
| Employees | 0 | — |
Legal name
Biomet 3i Nordic AB
Org number
5566418934
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
11 mars 2003
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall marknadsföra, sälja och vidareutveckla produkter och tjänster inom verksamhetsområdet oral rekonstruktion samt bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −160 | −20 | −1 | −112 | −214 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −160 | −20 | −1 | −112 | −214 |
| Net financials | −15 | −9 | −1 | −2 | — |
| Profit before tax | −174 | −29 | −2 | −114 | −214 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −174 | −29 | −2 | −114 | −214 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 16 664 | 16 585 | 16 580 | 16 466 | 16 300 |
| Equity | 16 609 | 16 580 | 16 578 | 16 464 | 16 249 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 55 | 5 | 3 | 3 | 51 |
| Total debt | 55 | 5 | 3 | 3 | 51 |
EBITDA margin
-21400000.0%
This company
15.8%
Market median
-135443138% vs market
20172021
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20172021
Return on equity
-1.3%
This company
18.4%
Market median
-107% vs market
20172021
Net profit margin
-21400000.0%
This company
8.1%
Market median
-264197631% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JF Liquidator | Liquidator | 2021 |
KJ Audit | Audit | 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biomet 3i Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Ståhl | Liquidator | 0 companies |
| Karl Jesper Lindvall | Audit | 0 companies |
| Pedro Bruno Ferreira Malha | Board of Directors | 0 companies |
| Thomas Edwin Oglesby | Deputy Board Member | 0 companies |